D2 and D1 of LAG3 and FD of FGL1 will be the LAG3-FGL1 relationship domains. Finally, high FGL1 and LAG3 appearance induces gefitinib and EGFR-TKI level of resistance, and anti-PD-1 therapy level of resistance, respectively. We present a thorough summary of the function of LAG3/FGL1 in tumor, suggesting book anti-tumor Continue Reading